EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Mayo Clinic Hospital, Phoenix, Arizona, United States

University of Southern California, Los Angeles, California, United States

Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

Stanford Cancer Institute, Palo Alto, California, United States

University of California, San Francisco, California, United States

UF Health Neuromedicine, Gainesville, Florida, United States

Mayo Clinic - Florida, Jacksonville, Florida, United States

Miami Cancer Institute, Miami, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

Northwestern Memorial Hospital, Chicago, Illinois, United States

University of Kentucky Medical Center, Lexington, Kentucky, United States

University of Maryland, Baltimore, Maryland, United States

Tufts Medical Center, Boston, Massachusetts, United States

Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States

Mayo Clinic - Rochester, Rochester, Minnesota, United States

Washington University, St Louis, Missouri, United States

Renown Regional Medical Center, Reno, Nevada, United States

John Theurer Cancer Center/ Hackensack Meridian Health, Hackensack, New Jersey, United States

Northwell Health, Lake Success, New York, United States

Columbia University Irving Medical Center, New York, New York, United States

Montefiore Medical Center- Montefiore Medical Park, The Bronx, New York, United States

Duke University Medical Center, Durham, North Carolina, United States

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

The Cleveland Clinic, Cleveland, Ohio, United States

Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Clinical Trials Organization, Philadelphia, Pennsylvania, United States

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

Rhode Island Hospital, Providence, Rhode Island, United States

The University of Texas, Houston, Texas, United States

University of Texas, MD Anderson Cancer Center, Houston, Texas, United States

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States

Inova Schar Cancer Institute, Fairfax, Virginia, United States

Swedish Medical Center, Seattle, Washington, United States

The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

CHUM, Montreal, Quebec, Canada

Montreal Neurological Institute-Hospital, Clinical Research Unit, Montreal, Quebec, Canada

Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke (CIUSSS de l'Estrie-CHUS), Sherbrooke, Quebec, Canada

Nemocnice Na Homolce, Prague, Czechia

Centre Hospitalier Universitaire de Lyon, Bron, France

Hopital de la Timone, Marseille, France

Hopital Saint-Louis, Paris, France

Groupe Hospitalier Pitie - Salpetriere, Paris, France

Institut Claudius Regaud, Toulouse, France

Charité Campus Virchow-Klinikum, Berlin, Germany

Universitätsklinikum Essen, Essen, Germany

University Hospital Frankfurt, Frankfurt, Germany

Rambam Medical Center, Haifa, Israel

Rabin Medical Center- Beilinson Hospital, Petah Tikva, Israel

Chaim Sheba Medical Center, Ramat Gan, Israel

Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel

Neuro-Oncologia Clinica Ospedale Molinette - AOU Città della Salute e della Scienza di Torino, Torino, Torino, Italy

Ospedale Bellaria, Bologna, Italy

Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

Ospedale del Mare, Naples, Italy

UOC Oncologia Medica 1 Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy

IRCCS Istituto Clinico Humanitas, Rozzano, Italy

U.O.C. Immunoterapia Oncologica A.O.U. Senese, Policlinico Santa Maria alle Scotte, Siena, Italy

Tokai University Hospital, Isehara, Kanagawa, Japan

Kyushu University Hospital, Fukuoka, Japan

Hokkaido University Hospital, Hokkaido, Japan

Kanazawa University Hospital, Ishikawa, Japan

Kumamoto University Hospital, Kumamoto, Japan

Kyoto University Hospital, Kyoto, Japan

Kyorin University Hospital, Mitaka, Japan

Nagoya University Hospital, Nagoya, Japan

Saitama Medical University International Medical Center, Saitama, Japan

Tohoku University Hospital, Sendai, Japan

National Cancer Center Hospital, Tokyo, Japan

Centrum Onkologii, Bydgoszcz, Poland

Narodowy Instytut Onkologii, Gliwice, Poland

Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika-Zakład Teleradioterapii, Lodz, Poland

Hospital Universitario Clínico San Carlos, Madrid, Madrid, Spain

Hospital Universitario Clínico San Carlos, Madrid, Madrid, Spain

Hospital Universitari Vall d'Hebron, Barcelona, Spain

Institut Català d'Oncologia de L'Hospitalet (ICO L'Hospitalet), Barcelona, Spain

Hospital Universitario Reina Sofia, Córdoba, Spain

Hospital Universitario Virgen de las Nieves, Granada, Spain

Hospital Universitario Ramón y Cajal, Madrid, Spain

Hospital Universitario 12 de Octubre, Madrid, Spain

Hospital Universitario La Paz, Madrid, Spain

Hospital Universitario Virgen del Rocio, Seville, Spain

Hospital Universitari i Politécnic La Fe, Valencia, Spain

University Hospital Basel Medical Oncology, Basel, Switzerland

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

University Hospital Zurich, Zurich, Switzerland

Queen Elizabeth, Birmingham, United Kingdom

Addenbrooke's Hospital (Cambridge University Hospitals NHS Foundation Trust), Cambridge, United Kingdom

Velindre Cancer Centre, Cardiff, United Kingdom

Western General Hospital, Edinburgh, United Kingdom

The Clatterbridge Cancer Centre (Clatterbridge Cancer Centre NHS Foundation Trust), Liverpool, United Kingdom

The Christie Hospital, Manchester, United Kingdom

Weston Park Hospital, Sheffield, United Kingdom

Southampton General Hospital, Southampton, United Kingdom

Royal Marsden, Sutton, United Kingdom